Nuvectis Pharma to Present at the H.C. Wainwright BioConnect Investor Conference

Reuters
2025.05.16 20:35
portai
I'm PortAI, I can summarize articles.

Nuvectis Pharma to Present at the H.C. Wainwright BioConnect Investor Conference Nuvectis Pharma Inc. (NASDAQ: NVCT), a clinical-stage biopharmaceutical company, will present at the 3rd Annual H.C. Wainwright Global BioConnect Investor Conference. The event is scheduled for May 20th, 2025, from 10:30 to 11:00 a.m. ET. Ron Bentsur, Chairman and CEO, will provide insights into the company's development of innovative precision medicines for oncology.

Nuvectis Pharma Inc. (NASDAQ: NVCT), a clinical-stage biopharmaceutical company, will present at the 3rd Annual H.C. Wainwright Global BioConnect Investor Conference. The event is scheduled for May 20th, 2025, from 10:30 to 11:00 a.m. ET. Ron Bentsur, Chairman and CEO, will provide insights into the company's development of innovative precision medicines for oncology.

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.